As the global competition in antibody-drug conjugates (ADCs) intensifies, one global pharma giant is looking to break into the Chinese market for these and other oncology products through a major new partnership.
Sanofi announced on 4 August a strategic alliance with Innovent Biologics, Inc. to jointly develop in the country...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://insights.citeline.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

